Latest "Ambrx Inc." News Stories

03:50 EDT 23rd October 2017 | BioPortfolio

Here are the most relevant search results for "Ambrx Inc." found in our extensive news archives from over 250 global news sources.

More Information about Ambrx Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Ambrx Inc. for you to read. Along with our medical data and news we also list Ambrx Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Ambrx Inc. Companies for you to search.

Showing "Ambrx" News Articles, all 2

Saturday 23rd September 2017

Winners Announced for 4th Annual World ADC Awards

San Diego, CA, September 24, 2017 --( The 4th Annual World ADC Awards Ceremony took place the evening of September 21 at the Sheraton San Diego Marina at 7:15pm. The Awards are sponsored by Abbvie (Headline Sponsor), Immunogen (Long Standing Contribution to the Field), Ambrx (Best ADC Platform Technology) and Medimmune (Best Publication 2016). The Awardees were shortlisted from over 16...

Friday 28th July 2017

Ambrx Inc Pharmaceuticals Healthcare Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

SummaryAmbrx Inc Ambrx is a biopharmaceutical company which focuses on the discovery and development of proteinbased medicines by using its expanded genetic code. The company's pipeline product candidate's portfolio includes ARX618 FGF21, PSMA ADC, CD70 ADC and AntiCD3 X Folate. It develops pipeline candidates for various therapeutic indications such as diabetes, oncology and heart failure. Ambrx ...

Quick Search

News Quicklinks